Trial Profile
Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Mar 2011
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Cancer metastases; Prostate cancer
- Focus Therapeutic Use
- Sponsors Novartis
- 05 Jun 2009 New trial record.